shutterstock_1905552877_nitpicker

nitpicker / Shutterstock.com

4 November 2021GenericsAlex Baldwin

EPO upholds Bayer's Xarelto dosage patents

Following two-day oral proceedings at the Munich Board of Appeal of the European Patent Office (EPO), the court has upheld the validity of a Bayer Pharmaceuticals’ dosing patent for Xarelto (rivaroxaban).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Cohausz & Florack hires senior technical duo

19 January 2023 Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.

Bayer and Boston hospitals collaborate on COPD lab

26 September 2019 Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Bayer and CRISPR close joint venture transaction

19 August 2016 Bayer has launched a partnership with CRISPR Therapeutics.

More on this story

Biotechnology

Cohausz & Florack hires senior technical duo

19 January 2023 Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.

Bayer and Boston hospitals collaborate on COPD lab

26 September 2019 Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Bayer and CRISPR close joint venture transaction

19 August 2016 Bayer has launched a partnership with CRISPR Therapeutics.

More on this story

Biotechnology

Cohausz & Florack hires senior technical duo

19 January 2023 Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.

Bayer and Boston hospitals collaborate on COPD lab

26 September 2019 Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Bayer and CRISPR close joint venture transaction

19 August 2016 Bayer has launched a partnership with CRISPR Therapeutics.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?